Novo Nordisk A/S (NVO)
Today's Latest Price: $70.74 USD
Updated Oct 23 7:00pm
Add NVO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
Novo Nordisk A S (NVO) Price Targets From Analysts
Use the tables below to see what analysts covering Novo Nordisk A S think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 22 | $83.46 | $52.27 | $71.39 | $71.25 | 0.2% |
NVO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.65 | 11 | 1 | 11 | 2 | 2 | 26 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of NVO is higher than 94.8% of all US stocks.
- Novo Nordisk A S's upside potential (average analyst target price relative to current price) is higher than 7.12% of Pharmaceutical Products stocks.
- The percent of analysts bearish on the stock of NVO is lower than 10.64% of Pharmaceutical Products stocks.
- NVO has a greater average analyst price target than 85.38% of Pharmaceutical Products stocks.
- NVO has a higher percentage of analysts bullish on the stock than 15.43% of Pharmaceutical Products stocks.
- Novo Nordisk A S's variance in analysts' estimates is less than 33.11% of all US stocks.
- NVO has a less change in bullishness amongst analysts than nearly 100% of all US stocks.
Stocks similar to Novo Nordisk A S in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GSK, GMAB and GILD.
Is NVO a Buy, Hold or Sell? See the POWR Ratings now!
